期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
[(99m)~Tc(CO)_3]^+ labeled histidine derivative containing 4-nitroimidazole:Synthesis,biodistribution as a tumor hypoxia imaging agent
1
作者 MEI Lei CHU Taiwei 《Nuclear Science and Techniques》 SCIE CAS CSCD 2011年第2期105-110,共6页
A novel histidine derivative containing 4-nitroimidazole,(S)-2-(4-((4-nitro-1H-imidazol-1-yl) methyl) benzamido)-3-(1H-imidazol-4-yl)propanoic acid (His-NI),was synthesized and labeled with [99mTc(CO)3(H2O)3]+.The tri... A novel histidine derivative containing 4-nitroimidazole,(S)-2-(4-((4-nitro-1H-imidazol-1-yl) methyl) benzamido)-3-(1H-imidazol-4-yl)propanoic acid (His-NI),was synthesized and labeled with [99mTc(CO)3(H2O)3]+.The tricarbonyl technetium complex,the 99mTc(CO)3-His-NI,showed a 99% yield under mild conditions at a low His-NI ligand concentration of 10-4 molL-1,and its biodistribution in mice bearing S180 tumor had a selective accumulation in tumor (2.01±0.40%ID/g at 1 h postinjection) and a slow clearance.The tumor/muscle ratio was 1.64 at 1 h,3.10 at 4 h,and 3.88 at 24 h,indicating that the 99mTc(CO)3-His-NI has a potential to image tumor hypoxia. 展开更多
关键词 硝基咪唑 衍生物 组氨酸 CO 肿瘤 合成 缺氧 显像剂
下载PDF
^(99m)Tc-HL91乏氧显像对肺部孤立性结节的临床诊断价值
2
作者 孙浩杰 袁晓梅 李莉 《新乡医学院学报》 CAS 2011年第4期496-497,共2页
目的探讨99m锝-4,9-二氮-3,3,10,10-四甲基十二烷-2,11-二酮肟(99mTc-HL91)乏氧显像诊断肺部孤立性结节的临床价值。方法对69例经计算机X射线断层扫描(CT)发现肺部孤立性结节患者进行肺活组织病理检查及行99mTc-HL91乏氧显像,对早期(4 h... 目的探讨99m锝-4,9-二氮-3,3,10,10-四甲基十二烷-2,11-二酮肟(99mTc-HL91)乏氧显像诊断肺部孤立性结节的临床价值。方法对69例经计算机X射线断层扫描(CT)发现肺部孤立性结节患者进行肺活组织病理检查及行99mTc-HL91乏氧显像,对早期(4 h)显像和延迟(24 h)显像结果进行半定量分析,并对病理及半定量分析结果进行比较。结果 99mTc-HL91乏氧显像诊断肺部孤立性结节肺癌的准确率为91.11%(41/45)。不同时相恶性组99mTc-HL91的摄取均明显高于良性组,差别有统计学意义(P<0.01)。恶性组24 h99mTc-HL91的摄取量明显高于4 h,差别有统计学意义(P<0.01)。结论 99mTc-HL91乏氧显像应用于诊断肺部孤立性结节具有较高的临床价值。 展开更多
关键词 肺部孤立性结节 乏氧 99m锝-4 9-二氮-3 3 10 10-四甲基十二烷-2 11-二酮肟
下载PDF
一种新型潜在^(99m)TcN核标记5-HT_(1A)脑受体显像剂的制备研究 被引量:2
3
作者 张现忠 周潘旺 +4 位作者 刘姣姣 黄艳 顾婷 陈妍伶 王学斌 《北京师范大学学报(自然科学版)》 CAS CSCD 北大核心 2006年第4期395-400,共6页
合成了一种含有(2-甲氧基苯基)哌嗪(MPP)活性基团的4-[(2-甲氧基苯基)哌嗪基]-二硫代甲酸盐(MPPDTF),式中MPP基团是与5-HT1A脑受体具有高亲和性的药效团.通过元素分析、红外光谱(IR)、核磁(1HNMR)及质谱(EI-MS)等表征确认了配体的结构.9... 合成了一种含有(2-甲氧基苯基)哌嗪(MPP)活性基团的4-[(2-甲氧基苯基)哌嗪基]-二硫代甲酸盐(MPPDTF),式中MPP基团是与5-HT1A脑受体具有高亲和性的药效团.通过元素分析、红外光谱(IR)、核磁(1HNMR)及质谱(EI-MS)等表征确认了配体的结构.99mTcN核标记配合物按两步法制备:先由药盒法制得中间体([99mTc≡N]i2nt+),然后通过配体交换反应制得最终标记配合物(99mTcN(MPPDTF)2).配体交换反应条件在配体用量、反应pH值、反应温度以及反应时间等方面经过细致的优化,在最佳标记条件下可制得放射化学纯度大于98%的最终配合物.中间体和最终配合物的制备均经过TLC和HPLC鉴定.99mTcN(MPPDTF)2配合物为中性、脂溶性配合物(P=49.5±3.5,n=3),在室温下放置6 h以上放化纯无明显变化. 展开更多
关键词 5-HT1A受体 4-[(2-甲氧基苯基)哌嗪基]-二硫代甲酸盐 ^99mTcN核配合物 显像剂
下载PDF
Synthesis and biological evaluation of ^(99m)Tc-HEDTA/HYNIC-MPP4 complex for 5-HT1A receptor imaging 被引量:1
4
作者 FAN WeiWei LIN Yan +5 位作者 ZHANG XianZhong PANG Yan MA Cong TANG ZhiGang ZHANG JunBo WANG XueBin 《Science China Chemistry》 SCIE EI CAS 2009年第5期590-598,共9页
5-HT1A receptor is associated with a variety of pathophysiology of neuropsychiatric disorders. Accordingly, we have synthesized a new 5-HT1A receptor ligand (HYNIC-MPP4) and labeled it with 99mTc using N-(2-hydroxyeth... 5-HT1A receptor is associated with a variety of pathophysiology of neuropsychiatric disorders. Accordingly, we have synthesized a new 5-HT1A receptor ligand (HYNIC-MPP4) and labeled it with 99mTc using N-(2-hydroxyethyl)ethylenediaminetriacetic acid (HEDTA) as coligand. 99mTc-HEDTA/HYNIC-MPP4 was prepared under pH 6 at room temperature. Biodistribution of 99mTc-HEDTA/HYNIC-MPP4 in normal mice showed that this complex had moderate brain uptake (0.60% ID·g-1 at 2 min p.i.) and good retention. The hippocampus had the highest radioactivity uptake at 2 min p.i. (1.84% ID·g-1). The ratio of Hipp/CB was 3.1 at 2 min p.i. and increased to 4.4 at 60 min p.i. After blocking with 8-hydroxy-2-(dipropylamino) tetralin, the uptake of hippocampus was decreased significantly from 1.84% ID·g-1 to 0.53% ID·g-1 at 2 min p.i., while the cerebellum had no significant decrease. This 99mTc complex could be a potent agent for 5-HT1A receptor imaging. 展开更多
关键词 5-HT1A receptor 99mTc N-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}-3-(6-hydrazinyl)pyridyl carboxamide(HYNIC-MPP4) BIODISTRIBUTION
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部